Crystalline pharmaceutical

Details for Australian Patent Application No. 2006222711 (hide)

Owner Abbott Laboratories

Inventors Porter, William; Fort, James J.; Niu, Yuping; Chemburkar, Sanjay; Henry, Rodger F.; Lechuga-Ballesteros, David; Dickman, Daniel A.

Agent Spruson & Ferguson

Pub. Number AU-A-2006222711

Parent 2001250920

Filing date 27 September 2006

Wipo publication date 19 October 2006

International Classifications

C07D 239/10 (2006.01) Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings

Event Publications

19 October 2006 Application Open to Public Inspection

  Published as AU-A-2006222711

19 October 2006 Complete Application Filed

14 October 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006222712-Inhibition of Cathepsin K Activity and the treatment and prevention of disease

2006222710-Commercial transaction system with third party referral